HUP9904204A3 - Naphthyridine derivatives, medicaments e.g. for asthma therapy containing them and intermediates - Google Patents

Naphthyridine derivatives, medicaments e.g. for asthma therapy containing them and intermediates

Info

Publication number
HUP9904204A3
HUP9904204A3 HU9904204A HUP9904204A HUP9904204A3 HU P9904204 A3 HUP9904204 A3 HU P9904204A3 HU 9904204 A HU9904204 A HU 9904204A HU P9904204 A HUP9904204 A HU P9904204A HU P9904204 A3 HUP9904204 A3 HU P9904204A3
Authority
HU
Hungary
Prior art keywords
medicaments
intermediates
naphthyridine derivatives
asthma therapy
therapy containing
Prior art date
Application number
HU9904204A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUP9904204A2 publication Critical patent/HUP9904204A2/hu
Publication of HUP9904204A3 publication Critical patent/HUP9904204A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HU9904204A 1996-10-28 1997-10-24 Naphthyridine derivatives, medicaments e.g. for asthma therapy containing them and intermediates HUP9904204A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622386.2A GB9622386D0 (en) 1996-10-28 1996-10-28 Organic compounds

Publications (2)

Publication Number Publication Date
HUP9904204A2 HUP9904204A2 (hu) 2000-05-28
HUP9904204A3 true HUP9904204A3 (en) 2000-06-28

Family

ID=10802050

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904204A HUP9904204A3 (en) 1996-10-28 1997-10-24 Naphthyridine derivatives, medicaments e.g. for asthma therapy containing them and intermediates

Country Status (32)

Country Link
US (1) US6136821A (hu)
EP (1) EP0934320B1 (hu)
JP (1) JP4451496B2 (hu)
KR (1) KR100524329B1 (hu)
CN (1) CN1103773C (hu)
AR (1) AR009128A1 (hu)
AT (1) ATE236155T1 (hu)
AU (1) AU724471B2 (hu)
BR (1) BR9713280B1 (hu)
CA (1) CA2269946C (hu)
CO (1) CO4910164A1 (hu)
CZ (1) CZ146699A3 (hu)
DE (1) DE69720493T2 (hu)
DK (1) DK0934320T3 (hu)
ES (1) ES2196377T3 (hu)
GB (1) GB9622386D0 (hu)
HK (1) HK1022305A1 (hu)
HU (1) HUP9904204A3 (hu)
ID (1) ID18623A (hu)
IL (2) IL129502A0 (hu)
MY (1) MY132642A (hu)
NO (1) NO312677B1 (hu)
NZ (1) NZ335363A (hu)
PE (1) PE10899A1 (hu)
PL (1) PL189280B1 (hu)
PT (1) PT934320E (hu)
SI (1) SI0934320T1 (hu)
SK (1) SK283562B6 (hu)
TR (1) TR199900920T2 (hu)
TW (1) TW399052B (hu)
WO (1) WO1998018796A1 (hu)
ZA (1) ZA979593B (hu)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1147087E (pt) * 1999-01-15 2005-09-30 Altana Pharma Ag Feantridina-n-oxidos com actividade de inibicao de pde-iv
JP2003502278A (ja) 1999-01-15 2003-01-21 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のｎ−オキシド
SK287231B6 (sk) 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
US6953774B2 (en) 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
PL365443A1 (en) 2001-01-31 2005-01-10 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
CA2436535A1 (en) 2001-01-31 2002-08-08 Prizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
WO2002060896A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Ether derivatives useful as inhibitors of pde4 isozymes
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
WO2002094320A1 (fr) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions therapeutiques permettant de reparer la chondropathie
DE60233884D1 (de) * 2001-10-16 2009-11-12 Memory Pharmaceutical Corp 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen
MY130622A (en) 2001-11-05 2007-07-31 Novartis Ag Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
UA80418C2 (en) 2001-12-14 2007-09-25 Applied Research Systems Methods of inducing ovulation using phosphodiesterase inhibitor as non-polypeptide camp level modulator.and method of collecting oocytes for in vitro fertilization
AU2003295656B2 (en) 2002-11-19 2010-11-11 Memory Pharmaceuticals Corporation Pyridine N-oxide compounds as phosphodiesterase 4 inhibitors
GB0229281D0 (en) * 2002-12-16 2003-01-22 Novartis Ag Organic compounds
WO2004094375A2 (en) * 2003-04-16 2004-11-04 Memory Pharmaceuticals Corporation 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
RU2379292C2 (ru) * 2003-04-18 2010-01-20 Мемори Фармасьютиклз Корпорейшн Производные пиразола в качестве ингибиторов фосфодиэстеразы 4
TW200519106A (en) 2003-05-02 2005-06-16 Novartis Ag Organic compounds
MY141255A (en) 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
US20090042951A1 (en) * 2004-02-20 2009-02-12 Robert Danziger Blood Pressure Reduction in Salt-Sensitive Hypertension
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
US20050282818A1 (en) * 2004-06-22 2005-12-22 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
CN101018791A (zh) * 2004-09-14 2007-08-15 诺瓦提斯公司 通过8－卤代－1,7－萘啶衍生物与有机硼酸衍生物反应来制备6,8－取代的1,7－萘啶衍生物的方法以及该方法的中间体
EP1799673A1 (en) 2004-10-15 2007-06-27 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
JP2008517066A (ja) * 2004-10-20 2008-05-22 メモリー ファーマシューティカルス コーポレーション ホスホジエステラーゼ４阻害剤
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
JP2006241111A (ja) * 2005-03-04 2006-09-14 Univ Nihon 新規ベンゾフロキサン及びその合成法
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP2532679B1 (en) 2005-10-21 2017-04-12 Novartis AG Human antibodies against il13 and therapeutic uses
EA200801128A1 (ru) * 2005-10-21 2008-10-30 Глэксо Груп Лимитед Пери-конденсированные трициклические соединения, полезные в качестве антибактериальных средств
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1963324B1 (en) 2005-12-22 2010-04-21 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
GB0526244D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
GB0601951D0 (en) * 2006-01-31 2006-03-15 Novartis Ag Organic compounds
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
KR20080110925A (ko) 2006-04-21 2008-12-19 노파르티스 아게 아데노신 ａ２ａ 수용체 효능제로서 사용하기 위한 퓨린 유도체
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008037477A1 (en) 2006-09-29 2008-04-03 Novartis Ag Pyrazolopyrimidines as p13k lipid kinase inhibitors
JP2010508315A (ja) 2006-10-30 2010-03-18 ノバルティス アーゲー 抗炎症剤としてのヘテロ環式化合物
EA016199B1 (ru) 2007-01-10 2012-03-30 Айрм Ллк Соединения и композиции как ингибиторы активирующей канал протеазы
US8318935B2 (en) 2007-05-07 2012-11-27 Novartis Ag Organic compounds 75074
JP5455922B2 (ja) 2007-12-10 2014-03-26 ノバルティス アーゲー 有機化合物
ES2442930T3 (es) 2008-01-11 2014-02-14 Novartis Ag Pirimidinas como inhibidores de cinasas
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
WO2009150137A2 (en) 2008-06-10 2009-12-17 Novartis Ag Organic compounds
DK2391366T3 (da) 2009-01-29 2013-01-07 Novartis Ag Substituerede benzimidazoler til behandling af astrocytomer
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
AU2010283806A1 (en) 2009-08-12 2012-03-01 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
JP5819831B2 (ja) 2009-08-17 2015-11-24 インテリカイン， エルエルシー 複素環式化合物およびそれらの使用
KR20120089463A (ko) 2009-08-20 2012-08-10 노파르티스 아게 헤테로시클릭 옥심 화합물
WO2011050325A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
MX2013000537A (es) 2010-07-14 2013-01-29 Novartis Ag Compuestos heterociclicos agonistas del receptor ip.
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
WO2012107500A1 (en) 2011-02-10 2012-08-16 Novartis Ag [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
WO2012116237A2 (en) 2011-02-23 2012-08-30 Intellikine, Llc Heterocyclic compounds and uses thereof
BR112013021638A2 (pt) 2011-02-25 2016-08-02 Irm Llc "compostos inibidores de trk, seu uso e composições que os compreendem"
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
EP2755976B1 (en) 2011-09-15 2018-07-18 Novartis AG 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038386A1 (en) 2011-09-16 2013-03-21 Novartis Ag Heterocyclic compounds for the treatment of cystic fibrosis
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038390A1 (en) 2011-09-16 2013-03-21 Novartis Ag N-substituted heterocyclyl carboxamides
US20130209543A1 (en) 2011-11-23 2013-08-15 Intellikine Llc Enhanced treatment regimens using mtor inhibitors
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP2802589B1 (en) 2012-01-13 2016-01-06 Novartis AG Fused pyrroles as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
CA2868202C (en) 2012-04-03 2021-08-10 Novartis Ag Combination products with tyrosine kinase inhibitors and their use
JP5907006B2 (ja) * 2012-09-04 2016-04-20 エヌ・イーケムキャット株式会社 ビフェニル化合物の合成方法
JP5907005B2 (ja) * 2012-09-04 2016-04-20 エヌ・イーケムキャット株式会社 ビフェニル化合物の合成方法
CN105189500A (zh) 2013-02-13 2015-12-23 诺华股份有限公司 Ip受体激动剂杂环化合物
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
CA2906542A1 (en) 2013-03-15 2014-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof
TW201605450A (zh) 2013-12-03 2016-02-16 諾華公司 Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
PT3134396T (pt) 2014-04-24 2019-12-16 Novartis Ag Derivados de amino piridina como inibidores da fosfatidilinositol 3-quinase
AU2014391610B2 (en) 2014-04-24 2018-01-25 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
BR112016024533A8 (pt) 2014-04-24 2021-03-30 Novartis Ag derivados de amino pirazina como inibidores de fosfatidilinositol 3-cinase ou sal, seu uso, e composição e combinação farmacêuticas
US9741941B2 (en) 2014-04-29 2017-08-22 Universal Display Corporation Organic electroluminescent materials and devices
WO2016011658A1 (en) 2014-07-25 2016-01-28 Novartis Ag Combination therapy
CA2954862A1 (en) 2014-07-31 2016-02-04 Novartis Ag Combination therapy
AU2020290094B2 (en) 2019-06-10 2024-01-18 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis
US20220306617A1 (en) 2019-08-28 2022-09-29 Novartis Ag Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54138572A (en) * 1978-04-17 1979-10-27 Kyowa Hakko Kogyo Co Ltd Novel isoquinoline derivative
JPS57203068A (en) * 1981-06-08 1982-12-13 Teikoku Hormone Mfg Co Ltd Novel 1-phenylisoquinoline derivative
FR2567520B1 (fr) * 1984-07-11 1987-01-02 Carpibem Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
JPS6230780A (ja) * 1985-04-17 1987-02-09 Ss Pharmaceut Co Ltd １，７−ナフチリジン誘導体及びこれを含有する薬剤
JPS6348277A (ja) * 1986-08-19 1988-02-29 Ss Pharmaceut Co Ltd ８−ピペラジニル−１，７−ナフチリジン誘導体
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
EP0970082A2 (en) * 1997-02-18 2000-01-12 Neurocrine Biosciences, Inc. Biazacyclic crf antagonists

Also Published As

Publication number Publication date
BR9713280A (pt) 1999-11-03
AU724471B2 (en) 2000-09-21
PL332738A1 (en) 1999-10-11
ID18623A (id) 1998-04-30
PL189280B1 (pl) 2005-07-29
CO4910164A1 (es) 2000-04-24
DE69720493D1 (de) 2003-05-08
ES2196377T3 (es) 2003-12-16
KR20000052832A (ko) 2000-08-25
CN1103773C (zh) 2003-03-26
NO991903L (no) 1999-04-21
BR9713280B1 (pt) 2010-12-14
EP0934320B1 (en) 2003-04-02
US6136821A (en) 2000-10-24
SK283562B6 (sk) 2003-09-11
EP0934320A1 (en) 1999-08-11
IL129502A0 (en) 2000-02-29
ZA979593B (en) 1998-04-28
ATE236155T1 (de) 2003-04-15
AU6908498A (en) 1998-05-22
TR199900920T2 (xx) 1999-06-21
TW399052B (en) 2000-07-21
CA2269946C (en) 2007-01-23
MY132642A (en) 2007-10-31
NO991903D0 (no) 1999-04-21
JP4451496B2 (ja) 2010-04-14
SI0934320T1 (en) 2003-08-31
CZ146699A3 (cs) 1999-08-11
PE10899A1 (es) 1999-03-03
JP2001502717A (ja) 2001-02-27
DK0934320T3 (da) 2003-07-14
CN1234800A (zh) 1999-11-10
WO1998018796A1 (en) 1998-05-07
DE69720493T2 (de) 2003-12-24
HUP9904204A2 (hu) 2000-05-28
GB9622386D0 (en) 1997-01-08
NZ335363A (en) 2000-11-24
PT934320E (pt) 2003-07-31
IL129502A (en) 2006-10-05
SK55799A3 (en) 1999-10-08
AR009128A1 (es) 2000-03-08
HK1022305A1 (en) 2000-08-04
KR100524329B1 (ko) 2005-11-01
CA2269946A1 (en) 1998-05-07
NO312677B1 (no) 2002-06-17

Similar Documents

Publication Publication Date Title
HUP9904204A3 (en) Naphthyridine derivatives, medicaments e.g. for asthma therapy containing them and intermediates
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
HK1020956A1 (en) Oxadiazoles, processes for their preparation and their use as medicaments
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
ZA972685B (en) Medicaments.
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
AU6884798A (en) Acoustic respiratory therapy apparatus
HUP9601652A1 (en) Piridyl-naphthalene derivatives, process for the preparation thereof, and intermediates thereof
HUP9702534A3 (en) Propiophenone derivatives, process for preparing them and medicaments containing the said compounds
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
EP0718287A3 (de) Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendungen und Verfahren zu ihrer Herstellung
HUP9701270A3 (en) Neuraminic acid derivatives, medicaments containing them and their use for producing medicaments
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
ZA979731B (en) Treatment of asthma.
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
HUP0100939A3 (en) Spiropiperidine derivatives, medicaments containing them and their use
AU3027297A (en) New thiazolidinediones, process for preparing the same and medicaments containing the same
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
ZA976735B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them.
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
NZ295656A (en) Substituted tetracyclic azepine derivatives, medicaments and intermediates
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.